-
1
-
-
85008193429
-
EAUGuidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016
-
Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, Hernandez V, Kaasinen E, Palou J, Roupret M, van Rhijn BW, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R.EAUGuidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. European Urology 2016; doi:10.1016/j.eururo.2016.05.041
-
(2016)
European Urology
-
-
Babjuk, M.1
Bohle, A.2
Burger, M.3
Capoun, O.4
Cohen, D.5
Comperat, E.M.6
Hernandez, V.7
Kaasinen, E.8
Palou, J.9
Roupret, M.10
Van Rhijn, B.W.11
Shariat, S.F.12
Soukup, V.13
Sylvester, R.J.14
Zigeuner, R.15
-
2
-
-
33746624567
-
5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives
-
Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochemistry and Photobiology 2006;82(4):994-1015. doi:10.1562/2006-02-03-IR-794
-
(2006)
Photochemistry and Photobiology
, vol.82
, Issue.4
, pp. 994-1015
-
-
Fotinos, N.1
Campo, M.A.2
Popowycz, F.3
Gurny, R.4
Lange, N.5
-
3
-
-
84885429377
-
Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data
-
Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Dragoescu O, Ray E, Fradet Y, Karl A, Burgues JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data. European Urology 2013;64(5):846-54. doi:10.1016/j.eururo.2013.03.059
-
(2013)
European Urology
, vol.64
, Issue.5
, pp. 846-854
-
-
Burger, M.1
Grossman, H.B.2
Droller, M.3
Schmidbauer, J.4
Hermann, G.5
Dragoescu, O.6
Ray, E.7
Fradet, Y.8
Karl, A.9
Burgues, J.P.10
Witjes, J.A.11
Stenzl, A.12
Jichlinski, P.13
Jocham, D.14
-
4
-
-
84938063413
-
A network meta-analysis of therapeutic outcomes after new image technologyassisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging
-
Lee JY, Cho KS, Kang DH, Jung HD, Kwon JK, Oh CK, Ham WS, Choi YD. A network meta-analysis of therapeutic outcomes after new image technologyassisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging. BMC Cancer 2015;15:566. doi:10.1186/s12885-015-1571-8
-
(2015)
BMC Cancer
, vol.15
, pp. 566
-
-
Lee, J.Y.1
Cho, K.S.2
Kang, D.H.3
Jung, H.D.4
Kwon, J.K.5
Oh, C.K.6
Ham, W.S.7
Choi, Y.D.8
-
5
-
-
84865491226
-
Effects of fluorescent light-guided transurethral resection on nonmuscle-invasive bladder cancer: A systematic review and meta-analysis
-
Shen P, Yang J,WeiW, Li Y, Li D, Zeng H,Wang J. Effects of fluorescent light-guided transurethral resection on nonmuscle-invasive bladder cancer: A systematic review and meta-analysis. BJU International 2012;110(6 Pt B):E209-15. doi:10.1111/j.1464-410X.2011.10892.x
-
(2012)
BJU International
, vol.110
, Issue.6
, pp. E209-E215
-
-
Shen, P.1
Yang, J.2
Wei, W.3
Li, Y.4
Li, D.5
Zeng, H.6
Wang, J.7
-
6
-
-
84884151142
-
Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: A meta-analysis of randomized controlled trials
-
Yuan H, Qiu J, Liu L, Zheng S, Yang L, Liu Z, Pu C, Li J, Wei Q, Han P. Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: A meta-analysis of randomized controlled trials. PloS One 2013;8(9):e74142. doi:10.1371/journal.pone.0074142
-
(2013)
PloS One
, vol.8
, Issue.9
, pp. e74142
-
-
Yuan, H.1
Qiu, J.2
Liu, L.3
Zheng, S.4
Yang, L.5
Liu, Z.6
Pu, C.7
Li, J.8
Wei, Q.9
Han, P.10
-
7
-
-
84920780781
-
Preferred reporting items for systematic reviewand meta-analysis protocols (PRISMA-P) 2015 statement
-
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P. Preferred reporting items for systematic reviewand meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 2015;4:1. doi:10.1186/2046-4053-4-1
-
(2015)
Systematic Reviews
, vol.4
, pp. 1
-
-
Moher, D.1
Shamseer, L.2
Clarke, M.3
Ghersi, D.4
Liberati, A.5
Petticrew, M.6
Shekelle, P.7
Stewart, L.A.8
Group, P.-P.9
-
8
-
-
43549092286
-
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
-
Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC medical Research Methodology 2008;8:22. doi:10.1186/1471-2288-8-22
-
(2008)
BMC Medical Research Methodology
, vol.8
, pp. 22
-
-
Lundh, A.1
Gotzsche, P.C.2
-
9
-
-
84882846134
-
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
-
Hartling L, Milne A, Hamm MP, Vandermeer B, Ansari M, Tsertsvadze A, Dryden DM. Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. Journal of Clinical Epidemiology 2013;66(9):982-93. doi:10.1016/j.jclinepi.2013.03.003
-
(2013)
Journal of Clinical Epidemiology
, vol.66
, Issue.9
, pp. 982-993
-
-
Hartling, L.1
Milne, A.2
Hamm, M.P.3
Vandermeer, B.4
Ansari, M.5
Tsertsvadze, A.6
Dryden, D.M.7
-
10
-
-
85012064911
-
The impact of blue light cystoscopy with hexaminolevulinate (HAL) on progresion of bladder cancer - A new analysis
-
Kamat AM, Cookson M, Witjes JA, Stenzl A, Grossman HB. The impact of blue light cystoscopy with hexaminolevulinate (HAL) on progresion of bladder cancer-a new analysis. Bladder Cancer 2016; doi:10.3233/BLC-160048
-
(2016)
Bladder Cancer
-
-
Kamat, A.M.1
Cookson, M.2
Witjes, J.A.3
Stenzl, A.4
Grossman, H.B.5
-
11
-
-
84890120075
-
Defining progression in nonmuscle invasive bladder cancer: It is time for a new, standard definition
-
Lamm D, Persad R, Brausi M, Buckley R,Witjes JA, Palou J, Bohle A, Kamat AM, Colombel M, Soloway M. Defining progression in nonmuscle invasive bladder cancer: It is time for a new, standard definition. The Journal of Urology 2014;191(1):20-7. doi:10.1016/j.juro.2013.07.102
-
(2014)
The Journal of Urology
, vol.191
, Issue.1
, pp. 20-27
-
-
Lamm, D.1
Persad, R.2
Brausi, M.3
Buckley, R.4
Witjes, J.A.5
Palou, J.6
Bohle, A.7
Kamat, A.M.8
Colombel, M.9
Soloway, M.10
-
12
-
-
70849130933
-
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors
-
Burger M, Stief CG, Zaak D, Stenzl A, Wieland WF, Jocham D, Otto W, Denzinger S. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors. Urology 2009;74(6):1282-6. doi:10.1016/j.urology.2009.06.088
-
(2009)
Urology
, vol.74
, Issue.6
, pp. 1282-1286
-
-
Burger, M.1
Stief, C.G.2
Zaak, D.3
Stenzl, A.4
Wieland, W.F.5
Jocham, D.6
Otto, W.7
Denzinger, S.8
-
13
-
-
79953033797
-
Photodynamic diagnosis of nonmuscle invasive bladder cancer using hexaminolevulinic acid
-
Dragoescu O, Tomescu P, Panus A, Enache M, Maria C, Stoica L, Plesea IE. Photodynamic diagnosis of nonmuscle invasive bladder cancer using hexaminolevulinic acid. Romanian Journal of Morphology and Embryology= Revue Roumaine De Morphologie et Embryologie 2011;52(1):123-7.
-
(2011)
Romanian Journal of Morphology and Embryology= Revue Roumaine de Morphologie et Embryologie
, vol.52
, Issue.1
, pp. 123-127
-
-
Dragoescu, O.1
Tomescu, P.2
Panus, A.3
Enache, M.4
Maria, C.5
Stoica, L.6
Plesea, I.E.7
-
14
-
-
84857034477
-
Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: Does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
-
Geavlete B, Multescu R, Georgescu D, Jecu M, Stanescu F, Geavlete P. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: Does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)? BJU International 2012;109(4):549-56. doi:10.1111/j.1464-410X. 2011.10374.x
-
(2012)
BJU International
, vol.109
, Issue.4
, pp. 549-556
-
-
Geavlete, B.1
Multescu, R.2
Georgescu, D.3
Jecu, M.4
Stanescu, F.5
Geavlete, P.6
-
15
-
-
84864582376
-
Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: Does it reduce recurrences?
-
Karaolides T, Skolarikos A, Bourdoumis A, Konandreas A, Mygdalis V, Thanos A, Deliveliotis C. Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: Does it reduce recurrences? Urology 2012; 80(2):354-9. doi:10.1016/j.urology.2012.03.067
-
(2012)
Urology
, vol.80
, Issue.2
, pp. 354-359
-
-
Karaolides, T.1
Skolarikos, A.2
Bourdoumis, A.3
Konandreas, A.4
Mygdalis, V.5
Thanos, A.6
Deliveliotis, C.7
-
16
-
-
77957834145
-
Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer
-
Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. The Journal of Urology 2010;184(5):1907-13. doi:10.1016/j.juro.2010.06.148
-
(2010)
The Journal of Urology
, vol.184
, Issue.5
, pp. 1907-1913
-
-
Stenzl, A.1
Burger, M.2
Fradet, Y.3
Mynderse, L.A.4
Soloway, M.S.5
Witjes, J.A.6
Kriegmair, M.7
Karl, A.8
Shen, Y.9
Grossman, H.B.10
-
17
-
-
84862154878
-
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy
-
Grossman HB, Stenzl A, FradetY, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M. Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. The Journal of Urology 2012;188(1):58-62. doi:10.1016/j.juro.2012.03.007
-
(2012)
The Journal of Urology
, vol.188
, Issue.1
, pp. 58-62
-
-
Grossman, H.B.1
Stenzl, A.2
Fradet, Y.3
Mynderse, L.A.4
Kriegmair, M.5
Witjes, J.A.6
Soloway, M.S.7
Karl, A.8
Burger, M.9
-
18
-
-
84946748949
-
Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder
-
Gakis G,TodenhöferT, Braun M, Fend F, Stenzl A, Perner S. Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder. Scandinavian Journal of Urology 2015;49(5):382-7. doi:10.3109/21681805.2015.1040449
-
(2015)
Scandinavian Journal of Urology
, vol.49
, Issue.5
, pp. 382-387
-
-
Gakis, G.1
Todenhöfer, T.2
Braun, M.3
Fend, F.4
Stenzl, A.5
Perner, S.6
-
19
-
-
84870506781
-
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder
-
International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder C
-
Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder C. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. European Urology 2013;63(1):45-57. doi:10.1016/j.eururo.2012.08.009
-
(2013)
European Urology
, vol.63
, Issue.1
, pp. 45-57
-
-
Gakis, G.1
Efstathiou, J.2
Lerner, S.P.3
Cookson, M.S.4
Keegan, K.A.5
Guru, K.A.6
Shipley, W.U.7
Heidenreich, A.8
Schoenberg, M.P.9
Sagaloswky, A.I.10
Soloway, M.S.11
Stenzl, A.12
-
20
-
-
84894420746
-
EAU guidelines on muscleinvasive and metastatic bladder cancer: Summary of the 2013 guidelines
-
European Association of U
-
Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A, European Association of U. EAU guidelines on muscleinvasive and metastatic bladder cancer: Summary of the 2013 guidelines. European Urology 2014;65(4):778-92. doi:10.1016/j.eururo.2013.11.046
-
(2014)
European Urology
, vol.65
, Issue.4
, pp. 778-792
-
-
Witjes, J.A.1
Comperat, E.2
Cowan, N.C.3
De Santis, M.4
Gakis, G.5
Lebret, T.6
Ribal, M.J.7
Van Der Heijden, A.G.8
Sherif, A.9
-
21
-
-
84929951733
-
Fluorescence-guided bladder tumour resection: Impact on survival after radical cystectomy
-
Gakis G, Ngamsri T, Rausch S, Mischinger J, Todenhofer T, Schwentner C, Schmid MA, Hassan FA, Renninger M, Stenzl A. Fluorescence-guided bladder tumour resection: Impact on survival after radical cystectomy. World Journal of Urology 2015;33 (10):1429-37. doi:10.1007/s00345-015-1485-8
-
(2015)
World Journal of Urology
, vol.33
, Issue.10
, pp. 1429-1437
-
-
Gakis, G.1
Ngamsri, T.2
Rausch, S.3
Mischinger, J.4
Todenhofer, T.5
Schwentner, C.6
Schmid, M.A.7
Hassan, F.A.8
Renninger, M.9
Stenzl, A.10
-
22
-
-
72149096004
-
Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: Results of a prospective, randomised, multicentre study
-
Schumacher MC, Holmang S, Davidsson T, Friedrich B, Pedersen J, Wiklund NP. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: Results of a prospective, randomised, multicentre study. European Urology 2010;57(2):293-9. doi:10.1016/j.eururo.2009.10.030
-
(2010)
European Urology
, vol.57
, Issue.2
, pp. 293-299
-
-
Schumacher, M.C.1
Holmang, S.2
Davidsson, T.3
Friedrich, B.4
Pedersen, J.5
Wiklund, N.P.6
-
23
-
-
79952014223
-
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: A multicenter randomized, double-blind, placebo-controlled trial
-
Stenzl A, Penkoff H, Dajc-Sommerer E, Zumbraegel A, Hoeltl L, Scholz M, Riedl C, Bugelnig J, Hobisch A, Burger M, Mikuz G, Pichlmeier U. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: A multicenter randomized, double-blind, placebo-controlled trial. Cancer 2011;117(5):938-47. doi:10.1002/cncr.25523
-
(2011)
Cancer
, vol.117
, Issue.5
, pp. 938-947
-
-
Stenzl, A.1
Penkoff, H.2
Dajc-Sommerer, E.3
Zumbraegel, A.4
Hoeltl, L.5
Scholz, M.6
Riedl, C.7
Bugelnig, J.8
Hobisch, A.9
Burger, M.10
Mikuz, G.11
Pichlmeier, U.12
-
24
-
-
84973091674
-
Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: Recommendations from the international bladder cancer group
-
Kamat AM, Sylvester RJ, Bohle A, Palou J, Lamm DL, Brausi M, Soloway M, Persad R, Buckley R, Colombel M, Witjes JA. Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2016;34(16):1935-44. doi:10.1200/JCO.2015.64.4070
-
(2016)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.34
, Issue.16
, pp. 1935-1944
-
-
Kamat, A.M.1
Sylvester, R.J.2
Bohle, A.3
Palou, J.4
Lamm, D.L.5
Brausi, M.6
Soloway, M.7
Persad, R.8
Buckley, R.9
Colombel, M.10
Witjes, J.A.11
|